Twenty women were given a bolus induction of propofol2. 0 mg.kg-I for elective caesarean section. Induction to delivery times rangedfromfive to fourteen minutes. At delivery the maternal venous (MV) concentrations ofpropofol rangedfrom 0.53 to 1.48 pg.mt-I umbilical vein (UV) 0.39 to 1.4 pg.mt-Iand umbilical artery (UA) 0.34 to 0.68 pg.mt-I MV propofol concentrations were always higher than corresponding UV concentrations. The mean (95% confidence interval) UVIMVratio was 0.65 (0.56-0. 74) and the mean UAIUVratio was 1. 07 (0.99-1.15). Neither ratio was shown to be correlated with induction to delivery time. Distribution of propofol is rapid across the placenta and in the fetus. Apgar scores were higher with shorter incision to delivery times but were not correlated to umbilical levels of propofol.
(NACS) were satisfactory. With longer I-D times, maternal and neonatal propofol levels will be lower and it is not possible to extrapolate these results to faster deliveries. There are obstetric units, including our own, which routinely have much shorter 1-0 times.
The aim of this study was to investigate the early placental transfer of propofol when maternal propofol levels are relatively high.
MATERIALS AND METHODS
After approval by the Chinese University Ethics Committee, twenty ASA I Chinese women with normal term singleton pregnancies for elective caesarean section gave their informed consent to be studied. Patients were excluded if there was evidence of pregnancy-induced hypertension, preeclampsia, overt supine hypotension, diabetes, intra-uterine growth retardation or other fetal abnormality. All patients had normal electrolytes and liver function tests.
All women were given ranitidine 150 mg orally the night before and again two hours before surgery. Patients were transported to theatre lying on their side and a 15 degree left lateral tilt was maintained on the operating table. An intravenous catheter was inserted in the left forearm for drug and fluid administration and a long venous catheter inserted in the other arm for blood sampling. Sodium citrate 0.3M, 30 ml was given orally for five minutes before induction and monitoring of blood pressure and electrocardiogram were established. After three minutes of preoxygenation, propofol 2 mg.kg·! IV was given over 20 seconds followed by suxamethonium 1.5 mg.kg·! while cricoid pressure was applied. After tracheal intubation, anaesthesia was maintained with 50% nitrous oxide in oxygen and 1.0% enflurane. Neuromuscular blockade was maintained with atracurium 0.3 mg.kg-! and ventilation was controlled to maintain endtidal carbon dioxide levels of 4.0 to 4.5% using a carbon dioxide analyser (Normocap, Oatex Ltd).
Maternal venous (MV) blood for propofol levels was obtained at delivery. Umbilical arterial (UA) and umbilical venous (UV) blood were obtained by simultaneously double clamping a segment of umbilical cord. Blood was collected in lithium heparin tubes and stored at 4°C to await analysis.
The one and five-minute Apgar scores were recorded by a paediatrician. Patients were questioned the following day about awareness or dreaming during the period of the operation.
The propofol concentration in whole blood was determined by a method similar to that of Plummer. 6 Propofol in whole blood and internal standard thymol buffered with 0.1 M sodium dihydrogen phosphate buffer were extracted into cyclohexane. The organic extract was made alkaline by adding tetramethylammonium hydroxide and evaporated to dryness at 45°C under nitrogen. The residue was dissolved in 80 I.d acetonitrile and 50 ~l of the concentrate was analysed by high pressure liquid chromatography with fluorimetric detection. The calibration graphs were linear over the range 2 to 3000 ng.ml-! with coefficients of variation ranging from 1.0 to 8.0%. The between-batch coefficient of variance was 6.7% at 50 ng.ml-! and 4.8% at 3000 ng.ml·! while the limit of detection was approximately 2 ng.ml-!.
Kendall's rank correlation coefficient was used to test associations between Apgar scores, propofol levels and anaesthetic and delivery times. Significant correlations were accepted when P..s::0.05.
RESULTS
The twenty women had a mean (SO) age of 30.4 (4.8) years, weight of 63.6 (7.0) kg and height of 1.54 (0.08) metres. Five patients were primiparous.
Rapid sequence induction and intubation proceeded without difficulty in all patients. The induction to delivery (I-D) times ranged from 5.1 to 13.7 minutes with a mean (SO) of 10.5 (2.5) minutes. Uterine incision to delivery times were all less than 90 seconds. There was insufficient blood for analysis from only one umbilical artery. The concentrations of propofol are shown in Table 1 .
MV propofol concentrations were always higher than UV and as expected, both fell with longer 1-0 times (P < 0.01). The ratios UV /MV and U A/UV were not shown to be correlated to 1-0 time (P= 0.87 and 0.32 respectively).
Apgar scores were satisfactory in all neonates and active resuscitation was not required. There was no correlation found between scores and propofol levels. Apgar scores at one and five minutes were significantly higher with shorter I-D times (P < 0.05). (Figure 1 ).
No patient experienced awareness or dreaming during the procedure.
DISCUSSION
There are many factors which influence studies on placental transfer. 7, 8 Simple measurement of' fetal and maternal concentrations provide no information on the amount of drug transferred. Placental drug metabolism is probably not significant for propofol as only negligible glucuronidation activity has been reported in human placentas. 9 Diffusion across the membrane should be rapid as propofol is a low molecular weight, lipid-soluble and largely unionised drug. Propofol is a very weak acid and the concentration of the unionised form would be higher in the mother. The pKa of propofol in water is 11 so that changes in fetal pH would have little effect on the degree of ionisation.
Differences in protein binding must be considered when interpreting whole blood levels. Propofol is 97-98% protein bound in adults but there are no fetal data available. Maternal and fetal proteins generally have similar drug-binding affinity and differences in binding protein concentration are largely responsible for the fetal/maternal distribution of drugs at steady state. 1O An additional complication with propofol is that there is significant binding to the formed elements of blood. Despite all these problems, simultaneous sampling of maternal and umbilical' blood at delivery is the most practical and ethical experimental method available in humans to investigate placental transfer. After bolus induction, peak fetal thiopentone 11 ,12 and methohexitone 13 levels occur in 2-3 minutes and there is no reason to suspect that propofol should be different. UA levels may not be representative of brain levels due to the shunting that occurs in the fetal circulation. Nevertheless the levels in this study are well below the mean concentration (1.07 Ilg.ml-1) found in adults at the time of awakening after induction with propofol. 14 In another study,15 95% of adult patients were awake at propofol levels of 0.52 )lg.ml-I and baseline psychomotor performance was attained at a mean of 0.4 )lg.ml-I .
There is no information on the neonatal metabolism and elimination of propofol. Generally, neonatal glucuronidation is poorly developed but sulphation activity is similar to the aduitY Blood propofollevels did not correlate with Apgar scores though this may reflect the imprecise nature of this scale. However, another study could not show any correlation between NACS and propofol levels. 3 Apgar scores at one and five minutes were significantly higher (P < 0_05) with shorter I-D times despite generally higher levels of propofol. This is an unexpected finding though there have been similar reports after thiopentone. 17 The probable explanation is that propofol levels have fallen to clinically insignificant levels in the neonate and significant levels of nitrous oxide and enflurane have not been attained.
It is difficult to make conclusions about the change in UV/MV or UA/UV with respect to time as we are not taking serial samples in the same mother and fetus. If the UV /MV ratio is constant over the I-D time period studied, then equilibrium has already occurred across the placenta. UV and MV drug concentrations need not be equal. The mean UV /MV ratio of 0.65 is similar to the 0.70 reported in a study with longer I-D times 3 but less than that for ketamine l8 ,19 and recent studies with thiopentone. 20 ,21 This suggests comparatively less placental transfer of propofol but free drug may not be similarly distributed.
The mean UAlUV ratio of 1.07 at delivery suggests that distribution and equilibrium of propofol is rapid in the fetus. This confirms a previous report where the mean U A/UV ratio was 1.09 with I-D times of 13-45 minutes. 3 Studies with thiopentone have shown a mean UA/UV of 0.87 with I-D times of 8-22 minutes 20 and a mean UA/UV of 0.46 with I-D times of 4-7 minutes. 22 Distribution thus appears to be faster with propofol than with thiopentone.
After an induction dose of propofol 2 mg.kg -I, neonates have satisfactory Apgar scores despite rapid drug transfer across the placenta. However more detailed neonatal and maternal assessment is required to assess the suitability of propofol in obstetric anaesthetic practice.
